Important note
This AI stock analysis for UnitedHealth is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!
UnitedHealth - AI Stock Analysis
Analysis generated August 14, 2025
UnitedHealth Group Incorporated is an American multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services. UnitedHealth is one of the largest health insurers in the United States, providing a diverse range of services, including medical plans, pharmacy benefits, and healthcare services. UnitedHealth operates through two distinct segments: UnitedHealthcare, which offers health benefits programs, and Optum, which provides health services. The vast scale and diversified operations make UnitedHealth a critical player in the U.S. healthcare industry.
Fundamental Analysis
Revenue for the last quarter was $112 billion. This represents an increase of 1.86% compared to the previous quarter, indicating a steady growth rate. Compared to the same quarter last year, there's a significant increase of 14.06%, suggesting robust year-over-year growth. This is a positive indicator of the company’s ability to expand its market and services.
Net income for the last quarter was $3.41 billion. This marks a substantial decrease of 45.87% compared to the previous quarter, which is concerning. On a year-over-year basis, net income decreased by 19.21%, highlighting potential operational challenges or increased costs that need to be addressed.
EBITDA for the last quarter stood at $7.22 billion. This is a decline of 28.93% compared to the quarter before, and a decrease of 5.81% from the same quarter last year. These figures suggest a need for better cost management and efficiency improvements.
The current P/E ratio is 11.32, which could be considered low. This potentially indicates that the stock is undervalued, offering a bullish outlook. An undervalued stock may be attractive to investors seeking growth opportunities at a lower entry cost.
Technical Analysis
Today’s stock price is $271.81, reflecting a decrease of 9.57% compared to a month ago, and a more significant drop of 52.21% from a year ago. These declines could be a cause for concern among investors, especially those with a long-term horizon.
The trend is still identified as bullish, supported by a current SMA10 of 255.17, higher than the previous SMA10 of 252.09. This suggests a potential upward trend in price movement. However, the RSI of 78.5 indicates an overbought condition, which might suggest a short-term bearish outlook and potential for a price correction.
Alternative Data Analysis
In terms of job postings and employee sentiment, UnitedHealth has 76 open positions, up by 105% in the last couple of months. This indicates a potential growth and expansion phase, which is a healthy sign for the company’s future.
The business outlook among employees remains neutral, suggesting neither a positive nor negative internal sentiment.
Customer acquisition metrics show an estimated 1.9 million visitors to their webpage, up by 9% in the last couple of months. In addition, UnitedHealth has about 5,000 daily downloads of their mobile apps, which is an 18% increase in recent months. These data points indicate promising customer growth.
In terms of customer engagement, UnitedHealth has 12,000 followers on Instagram, up by 4% recently, showing increasing interest. The company also has 40,000 followers on Twitter, with stable engagement levels.
According to AltIndex’s AI score, which predicts stock prices by integrating multiple analysis types, UnitedHealth scores a 65. A score above 50 is generally seen as a buy signal.
Conclusion
The stock analysis for UnitedHealth presents a mixed picture. While fundamental analysis shows strong revenue growth, significant declines in net income and EBITDA raise concerns about operational efficiency. Technical indicators reflect a recent decline in stock price but suggest potential upward momentum in the near term. Alternative data, including employee sentiment and customer engagement, is bullish, indicating growth and increasing interest. Given the AI score of 65, UnitedHealth seems to be an attractive investment despite some recent challenges, and could be considered a buy for those willing to hold through short-term uncertainties in anticipation of long-term gains.
Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.
